Byron Cryer Selected Research

Byron Cryer Research Topics

Disease

11	Hemorrhage 11/2015 - 12/2002
10	Ulcer 01/2014 - 07/2003
7	Osteoarthritis 06/2015 - 02/2007
6	Pain (Aches) 01/2018 - 12/2003
5	Infections 07/2015 - 04/2004
4	Peptic Ulcer (Peptic Ulcers) 02/2024 - 07/2003
3	Opioid-Induced Constipation 01/2018 - 11/2014
3	Myocardial Infarction 03/2011 - 04/2004
3	Rheumatoid Arthritis 01/2010 - 02/2007
2	Nausea 12/2017 - 11/2014
2	Constipation 12/2017 - 11/2014
2	Inflammation (Inflammations) 11/2015 - 12/2003
2	Drug-Related Side Effects and Adverse Reactions 01/2015 - 11/2009
2	Esophagitis 10/2007 - 10/2002
1	Alcoholism (Alcohol Abuse) 02/2024
1	Acute Kidney Injury (Acute Renal Failure) 02/2024
1	COVID-19 02/2024
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/2017
1	Gastroparesis 01/2017
1	Paresis (Hemiparesis) 01/2017
1	Chronic Pain 11/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Stomach Ulcer (Gastric Ulcer) 01/2015
1	Diarrhea 11/2014
1	Gastritis 12/2013
1	Hepatitis C 09/2012
1	Chronic Hepatitis C 09/2012
1	Bone Fractures (Bone Fracture) 09/2012
1	Dyspepsia (Indigestion) 07/2011
1	Abdominal Pain (Pain, Abdominal) 07/2011
1	Orthostatic Hypotension (Postural Hypotension) 11/2008
1	Colorectal Neoplasms (Colorectal Cancer) 09/2008
1	Type 2 Diabetes Mellitus (MODY) 09/2008
1	Neoplasms (Cancer) 09/2008
1	Polyps 04/2008
1	Disease Progression 04/2008
1	Arthritis (Polyarthritis) 02/2007
1	Postmenopausal Osteoporosis 09/2005
1	Spasm (Spasms) 04/2004
1	Migraine Disorders (Migraine) 04/2004
1	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 02/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2002

Drug/Important Bio-Agent (IBA)

15	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2015 - 12/2002
10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 12/2002
6	Proton Pump InhibitorsIBA 12/2013 - 07/2003
4	Diclofenac (SR 38)FDA LinkGeneric 06/2015 - 02/2007
4	Celecoxib (Celebrex)FDA Link 01/2010 - 04/2004
3	Lubiprostone FDA Link 01/2018 - 11/2014
3	Naproxen (Naprosyn)FDA LinkGeneric 12/2008 - 04/2004
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2011 - 12/2002
2	EtoricoxibIBA 11/2008 - 02/2007
2	Hemoglobins (Hemoglobin)IBA 11/2008 - 09/2008
2	Ibuprofen (Motrin)FDA LinkGeneric 02/2005 - 04/2004
1	Methadone (Dolophine)FDA LinkGeneric 01/2018
1	CLC-2 Chloride ChannelsIBA 12/2017
1	AnticoagulantsIBA 07/2015
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 07/2015
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2011
1	Lipoxygenase (Lipoxygenase-1)IBA 10/2011
1	N 30IBA 07/2011
1	AntacidsIBA 07/2011
1	omega-Chloroacetophenone (Mace)IBA 03/2011
1	aspirin-phosphatidylcholineIBA 02/2011
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2010
1	Biomarkers (Surrogate Marker)IBA 11/2009
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2009
1	Etodolac (Lodine)FDA LinkGeneric 12/2008
1	rofecoxib (Vioxx)FDA Link 12/2008
1	Insulin (Novolin)FDA Link 04/2008
1	Lansoprazole (Prevacid)FDA LinkGeneric 10/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2007
1	SolutionsIBA 09/2005
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/2005
1	Serotonin (5 Hydroxytryptamine)IBA 04/2004
1	5-HT1 Serotonin ReceptorsIBA 04/2004
1	tegaserod (Zelnorm)FDA Link 04/2004
1	EnzymesIBA 12/2003
1	ProstaglandinsIBA 12/2003
1	Cimetidine (Biomet)FDA LinkGeneric 07/2003
1	Proteins (Proteins, Gene)FDA Link 07/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2003
1	AcidsIBA 07/2003
1	Pantoprazole (Protonix)FDA LinkGeneric 02/2003
1	Diphosphonates (Bisphosphonates)IBA 10/2002

Therapy/Procedure

7	Therapeutics 11/2015 - 02/2003
2	Glycemic Control 09/2008 - 04/2008
1	Artificial Respiration (Mechanical Ventilation) 02/2024
1	Critical Care (Surgical Intensive Care) 02/2024
1	Drug Therapy (Chemotherapy) 11/2009
1	Analgesia 12/2003
1	Vagotomy 07/2003
1	Secondary Prevention 12/2002